Isakoff et al. [23] used either cisplatin or carboplatin in 11 patients with BRCA1/2-driven BC, most of whom experienced prior chemotherapy; the response was seen in 6 (54.5%) women, however its duration was short (3.3 months). Here, BRCA1 is linked to breast cancer.